BF Biosciences (BFBIO): 2QFY25 Earning Preview - By Sherman Research
Feb 25 2025
Sherman Securities
- BF Biosciences (BFBIO) is set to announce its 2QFY25 results on February 27. The company is expected to report net profit of Rs203mn (EPS Rs2.3) compared to EPS of Rs1.31 during previous quarter.
- We expect BFBIO to post earnings growth of 77%QoQ. The rise in profitability is likely due to improved margins, as the company shifted its sales focus to highermargin products instead of low-margin toll-manufactured products.
- Additionally, other income from interest on unutilized IPO proceeds further contributed to earnings growth. Finance costs are also expected to decline by 29%QoQ, supported by the repayment of long-term loans and a reduction in the policy rate.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low